{"id":15782,"date":"2024-12-12T17:42:17","date_gmt":"2024-12-12T22:42:17","guid":{"rendered":"https:\/\/fibrocanada.ca\/?p=15782"},"modified":"2026-04-09T09:14:49","modified_gmt":"2026-04-09T13:14:49","slug":"university-of-calgary-fibromyalgia-study","status":"publish","type":"post","link":"https:\/\/www.fibrocanada.ca\/en\/university-of-calgary-fibromyalgia-study","title":{"rendered":"University of Calgary – iTBS – DCS in fibromyalgia study"},"content":{"rendered":"\n

<\/p>\n\n\n\n\n\n

Fibromyalgia Study at U of C in Calgary, AB.<\/h2>\n\n\n\n

The University of Calgary is conducting an ongoing fibromyalgia study into the effectiveness of transcranial magnetic stimulation (TMS), coupled with a medication called D-cycloserine in a double blind study as a treatment for fibromyalgia pain and many of the co-morbid symptoms such as depression and anxiety. The study involves the application of a protocol called intermittent theta-burst stimulation (iTBS) to a targeted spot in the dorsolateral prefrontal cortex of the brain. The study is being conducted by the team at Mathison Centre for Mental Health Research & Education by Dr. Alexander McGirr and team.<\/p>\n\n\n\n

\n

<\/p>\n\n\n\n

This study is being conducted in Calgary, Alberta and requires several in-person visits over a four week period to the clinic to receive the onboarding, treatment and follow up sessions.<\/p>\n\n\n\n

<\/p>\n<\/blockquote>\n\n\n\n

They are currently seeking participants in the Calgary area between the ages of 18-65. For further information, please visit clinicaltrials.gov<\/a> or contact neurostim@ucalgary.ca to discuss details with one of their research coordinators.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

To find out about other research and fibromyalgia studies, visit our Current Research<\/a> page to find out more.<\/p>\n\n\n

[\/trp_language]<\/p>\n\n\n\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

University of Calgary is conducting an ongoing fibromyalgia study to research the use of TMS and a medication for treatment of fibromyalgia pain and associated comorbidities.<\/p>\n","protected":false},"author":4,"featured_media":15868,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":""},"categories":[51],"tags":[],"class_list":["post-15782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-past","pmpro-has-access"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/posts\/15782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/comments?post=15782"}],"version-history":[{"count":1,"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/posts\/15782\/revisions"}],"predecessor-version":[{"id":23777,"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/posts\/15782\/revisions\/23777"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/media\/15868"}],"wp:attachment":[{"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/media?parent=15782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/categories?post=15782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/en\/wp-json\/wp\/v2\/tags?post=15782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}